National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 276902

Case Details

VAERS ID: 276902 (history)  
Age: 16.0  
Gender: Female  
Location: New Mexico  
Vaccinated:2007-03-16
Onset:2007-03-16
   Days after vaccination:0
Submitted: 2007-04-13
   Days after onset:28
Entered: 2007-04-16
   Days after submission:3
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 1427F / 1 UN / IM

Administered by: Other       Purchased by: Other
Symptoms: Alpha 1 foetoprotein normal, Anaemia, Blood human chorionic gonadotropin positive, Drug exposure during pregnancy, Ultrasound scan normal, Vaginal haemorrhage
SMQs:, Haematopoietic erythropenia (broad), Haemorrhage terms (excl laboratory terms) (narrow), Tumour markers (narrow), Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Normal pregnancy conditions and outcomes (narrow)

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: Iron (unspecified) 325 mg; vitamins (unspecified);
Current Illness: Pregnancy NOS (LMP=01/17/2007); Human papilloma virus infection; Anaemia; Cardiac murmur
Preexisting Conditions: Cholecystectomy
Diagnostic Lab Data: beta-human chorionic, positive; ultrasound, 5/31/07, normal; ultrasound, 10/21/07, normal; serum alpha-fetoprotein, 05/31/07, normal; Apgar score, 10/23/07, 8/9
CDC Split Type: WAES0703USA04967

Write-up: Information has been received from a Certified Medical Assistant for the pregnancy registry for GARDASIL concerning a 16 year old female patient with human papilloma virus who on 11-JAN-2007 was vaccinated IM with her first dose of Gardasil, lot#655619/1427F. On 16-MAR-2007 the patient, who was 9 weeks pregnant (positive pregnancy test) received her 2nd dose of Gardasil. The patient reported vaginal spotting during this pregnancy. Her outcome was unknown. Additional information has been requested. Follow-up information received 4/16/08 from the Certified nurse manager indicated that the now 17 year old patient delivered the baby on 10/23/07. The baby was a female weighing 7 lbs and 14 oz and length was 20 1/2 inches. Medications used during the pregnancy were prental vitamins once daily and iron (unspecified) 325 mg twice daily for anemia. Laboratory diagnostic tests included ultrasounds on 05/31/07 and 10/21/07 which were normal. A maternal serum alpha-fetoprotein screening (MSAFP) was performed on 05/31/2007 which was within normal limits. 07/08/2008 Initial and follow up information has been received from a Certified nurse manager for the pregnancy registry for GARDASIL concerning a 16 year old female patient with human papilloma virus and a heart murmur and a history of gallbladder removal and 0 pregnancies who on 11-JAN-2007 was vaccinated IM with her first dose of GARDASIL, lot #655619/1427F. On 16-MAR-2007 the patient, who was 9 weeks pregnant (positive pregnancy test) received her 2nd dose of GARDASIL. Her LMP was 17-JAN-2007 (estimated date of delivery 24-OCT-2007). The patient reported vaginal spotting during this pregnancy. Her outcome was unknown. Follow-up information received from the Certified nurse manager indicated that the now 17 year old patient delivered the baby on 23-Oct-2007. The baby was a female weighing 7 lbs and 14 oz and length was 20 1/2 inches. Her apgar score was 8/9. Medications used during pregnancy were prenatal vitamins once daily and iron (unspecified) 325 mg twice daily for anemia. Laboratory diagnostic tests included ultrasounds on 31-May-2007 and 21-Oct-2007 which were normal. A maternal serum alpha-fetoprotein screening was performed on 31-May-2007 which was within normal limits.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=276902


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166